Part 1 considered Dr. Kelvin Stott’s characterization of the innovation crisis in the pharmaceutical industry (here, here) and found his technology-based solution wanting. Improved productivity will require a new business model, one with transformative potential.
{iframe}https://www.forbes.com/sites/stanfleming/2018/09/11/how-to-fix-pharmas-innovation-crisis-part-2/#4c0caa821784{/iframe}